85 results
Page 3 of 5
424B5
82s 2ozrkgzxd43bg
9 Jan 20
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
qrcun
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
424B5
vsw2vw gn5w
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
EX-4.3
2stor5byt kx9ltxs
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
swihah8l6omkott2j7
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
rhg4xp
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
EX-1.2
70ccn6mvct623ah u3
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
POS AM
phecvz52
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-10.1
mxv31sjo
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm
8-K
EX-4.1
j1whvjm6o 55v8gjmt
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm
424B5
j7g pxmbm7ptan
7 Mar 19
Prospectus supplement for primary offering
4:28pm
8-K
EX-1.1
fdpzo0qb
7 Mar 19
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:15pm
424B5
eqb8w9t
6 Mar 19
Prospectus supplement for primary offering
4:07pm
POS AM
9j57uz4nfy65qf9h
26 Feb 19
Prospectus update (post-effective amendment)
4:47pm